Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biote (BTMD) EBT Margin (2021 - 2025)

Biote has reported EBT Margin over the past 5 years, most recently at 12.07% for Q4 2025.

  • Quarterly results put EBT Margin at 12.07% for Q4 2025, up 1452.0% from a year ago — trailing twelve months through Dec 2025 was 19.55% (up 1904.0% YoY), and the annual figure for FY2025 was 19.55%, up 1904.0%.
  • EBT Margin for Q4 2025 was 12.07% at Biote, down from 17.62% in the prior quarter.
  • Over the last five years, EBT Margin for BTMD hit a ceiling of 51.62% in Q3 2023 and a floor of 52.41% in Q2 2022.
  • Median EBT Margin over the past 5 years was 14.8% (2021), compared with a mean of 7.9%.
  • Biggest five-year swings in EBT Margin: crashed -8072bps in 2022 and later soared 4988bps in 2023.
  • Biote's EBT Margin stood at 14.8% in 2021, then soared by 101bps to 29.77% in 2022, then plummeted by -34bps to 19.77% in 2023, then crashed by -112bps to 2.45% in 2024, then skyrocketed by 593bps to 12.07% in 2025.
  • The last three reported values for EBT Margin were 12.07% (Q4 2025), 17.62% (Q3 2025), and 12.43% (Q2 2025) per Business Quant data.